Rare Pediatric Disease Priority Review Vouchers: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 30, 2019
April 11, 2024
c961e6ec-0020-4d39-9efc-529439e82e7e
Related Documents
Drug Master Files Guidance for Industry
Guidance DocumentNovember 15, 2019Center for Drug Evaluation and Research
Platform Technology Designation Program for Drug Development
Guidance DocumentMay 28, 2024Center for Drug Evaluation and Research
Pharmacogenomic Data Submissions
Guidance DocumentMarch 17, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox